Researcher interests: Genetic aspects of neoplastic transformation. Molecular mimicry of glycosaminoglycans by synthetic compounds. Selected topics in tissue dynamics; apoptosis and angiogenesis, in particular.
FACULTY / SCHOOL: School of Medicine - IMRIC

Selected Publications

Nitroxide delivery system for Nrf2 activation and skin protection (2015)| ScienceDirect | Read more
Shmuel Ben-Sasson, Havazelet Bianco-Peled, Maya Ben Yehuda Greenwald, Ron Kohen, Shira Anzi
Can nitroxides evoke the Keap1–Nrf2–ARE pathway in skin? (2014)| ScienceDirect | Read more
Shmuel Ben-Sasson, Ephraim Gazit, Ido Goldstein, Ira Kogan-Sakin, Iris Kamer, Jasmine Jacob-Hirsch, Marcelo Ehrlich, Naomi Goldfinger, Orit Leshem, Raanan Berger, Ran Brosh, Ron Loewenthal, Shalom Madar, Varda Rotter, Yehudit Cohen
TMPRSS2/ERG Promotes Epithelial to Mesenchymal Transition through the ZEB1/ZEB2 Axis in a Prostate Cancer Model (2011)| Plos One| Read more

Success Stories & related Product & PR

Raziel Therapeutics

Raziel Therapeutics is a clinical-stage pharmaceutical company developing a proprietary drug for the treatment of local fat reduction. The company is targeting obesity and related indications.



Tiltan Pharma’s proprietary anti-cancer platform is based on a combination of agents that target different, non-overlapping aspects of the angiogenic process. All of these agents are orally bio-available and FDA approved. The therapy cycle is a...


Contact for more information:

Shani Bullock
VP, Business Development, Healthcare
Contact ME: